Full Library
American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
Resource type
Journal Article
Authors/contributors
- Yong, Michelle K. (Author)
- Shigle, Terri Lynn (Author)
- Kim, Yae-Jean (Author)
- Carpenter, Paul A. (Author)
- Chemaly, Roy F. (Author)
- Papanicolaou, Genovefa A. (Author)
Title
American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
Abstract
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transpl. Infect. Dis. Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new approach was employed with the goal of better serving clinical providers by publishing each standalone topic in the infectious diseases series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious diseases and HCT content experts developed and answered FAQs. Topics were finalized with harmonized recommendations that were made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. The fourth topic in the series focuses on the management and treatment of cytomegalovirus (CMV) resistant and refractory infections. The diagnosis, definitions of resistant and refractory CMV, risk factors, virological genotypes and treatment algorithms are reviewed.
Publication
Transplantation and Cellular Therapy
Date
9/2021
Pages
S2666636721012525
Journal Abbr
Transplantation and Cellular Therapy
Accessed
10/23/21, 9:41 AM
ISSN
26666367
Short Title
American Society for Transplantation and Cellular Therapy Series
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Yong, M. K., Shigle, T. L., Kim, Y.-J., Carpenter, P. A., Chemaly, R. F., & Papanicolaou, G. A. (2021). American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation. Transplantation and Cellular Therapy, S2666636721012525. https://doi.org/10.1016/j.jtct.2021.09.010
GUIDELINES
HEME-ONC AND CELLULAR THERAPIES
Link to this record